REG - GlaxoSmithKline PLC - Result of AGM

GSKAnnouncement

05/05/2021 18:25

RNS Number : 6938X
  
GlaxoSmithKline PLC
  
05 May 2021
  
 

GlaxoSmithKline plc
 
Results of Annual General Meeting 
 
GlaxoSmithKline plc ('GSK') held its Annual General Meeting ('AGM') at 2.30pm on Wednesday 5 May 2021.
 
The statement made by the Chairman at the AGM will shortly be available to view on GSK's website at www.gsk.com. 
 
All valid proxy votes (whether submitted electronically or in hard copy form) were included in the poll taken at the meeting.
 
The table below shows the results of the poll on all 22 resolutions. The full text of the resolutions is contained in the Notice of AGM published on 30 March 2021, which is available on GSK's website at www.gsk.com. 
 
 




Resolution


Total votes for(1)(2)


%


Total votes against(2)


%


Total votes cast


Votes withheld(3)






1


Receive and adopt the 2020 Annual Report 


3,475,135,362


98.81


41,757,734


1.19


3,516,893,096


11,603,440




2


Approve the Annual report on remuneration  


3,272,132,033


93.14


240,932,159


6.86


3,513,064,192


15,444,148




3


Re-election of Sir Jonathan Symonds


3,499,343,831


99.52


16,763,629


0.48


3,516,107,460


12,371,547




4


Re-election of Dame Emma Walmsley 


3,507,017,955


99.68


11,159,384


0.32


3,518,177,339


10,359,075




5


Re-election of Charles Bancroft


3,506,975,009


99.74


9,026,131


0.26


3,516,001,140


12,472,435




6


Re-election of Vindi Banga


3,496,064,409


99.43


19,904,292


0.57


3,515,968,701


12,509,463




7


Re-election of Dr Hal Barron


3,507,018,967


99.69


10,733,599


0.31


3,517,752,566


10,738,305




8


Re-election of Dr Vivienne Cox


3,497,451,811


99.46


18,813,391


0.54


3,516,265,202


12,207,081




9


Re-election of Lynn Elsenhans


3,434,728,312


97.69


81,301,678


2.31


3,516,029,990


12,440,783




10


Re-election of Dr Laurie Glimcher


3,508,174,526


99.77


7,947,259


0.23


3,516,121,785


12,353,907




11


Re-election of Dr Jesse Goodman


3,506,872,640


99.74


9,131,605


0.26


3,516,004,245


12,467,159




12


Re-election of Iain Mackay


3,501,889,913


99.56


15,637,087


0.44


3,517,527,000


10,951,129




13


Re-election of Urs Rohner


3,484,061,208


99.10


31,702,634


0.90


3,515,763,842


12,752,529




14


Re-appointment of the auditor


3,512,936,007


99.84


5,521,996


0.16


3,518,458,003


10,024,350




15


Remuneration of the auditor


3,511,280,034


99.82


6,176,678


0.18


3,517,456,712


11,022,183




16


Authority for the company to make donations to political organisations and incur political expenditure


3,440,815,513


98.36


57,276,887


1.64


3,498,092,400


30,393,327




17


Authority to allot shares


3,362,807,250


95.66


152,632,653


4.34


3,515,439,903


13,038,799




18


Disapplication of pre-emption rights - general power(4)


3,368,593,428


95.88


144,660,127


4.12


3,513,253,555


15,222,364




19


Disapplication of pre-emption rights - in connection with an acquisition or specified capital investment(4)


3,291,504,396


93.68


221,978,886


6.32


3,513,483,282


14,999,454




20


Authority for the company to purchase its own shares(4)


3,449,168,275


98.36


57,436,714


1.64


3,506,604,989


21,875,135




21


Exemption from statement of senior statutory auditor's name


3,477,878,016


99.47


18,543,893


0.53


3,496,421,909


31,294,363




22


Authority for reduced notice of a general meeting other than an AGM(4)


3,286,542,818


93.50


228,494,172


6.50


3,515,036,990


12,675,849




 
 
Notes:
 




(1)


The "for" votes include those giving the Chairman discretion. In line with the notification issued to American Depositary Receipt (ADR) holders last year, GSK did not instruct its ADR Depositary to vote any unvoted ADRs in respect of the AGM resolutions.




(2)


Votes "for" and "against" are expressed as a percentage of the total votes cast.




(3)


A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes "for" or "against" a resolution.




(4)


Indicates Special Resolutions requiring a 75% majority. 




 
The following table provides further relevant information:
 




 


 
GSK's 
Twenty first
AGM
(2021)


 
GSK's 
Twentieth
AGM
(2020)




Issued share capital (excluding Treasury Shares)


5,031,444,276


5,017,091,542




Total votes cast and votes withheld lodged as a % of GSK's issued share capital (excluding Treasury Shares)


70.11%


72.60%




Total shareholder population


100,906


105,353




Total number of proxies lodged


6,089


6,268




% of shareholders who lodged proxies


6.03%


5.95%




 
The above poll results will shortly be available on the company's website at www.gsk.com. In accordance with Listing Rule 9.6.2, a copy of the resolutions, other than those concerning ordinary business, will be submitted to the UK Listing Authority and will in due course be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism 
 
 
V A Whyte
Company Secretary
 
5 May 2021
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
RAGDKPBBOBKDDPK